Our PBM audit defense team is second to none when it comes to getting results for our independent pharmacy clients. This week, Health Law Alliance secured a victory on behalf of a Florida pharmacy following a Caremark audit seeking more than $45,000 in alleged overpayments. During the audit, Caremark alleged that the pharmacy had failed to provide sufficient proof of copayment collection, prescription delivery, and patient-prescriber relationships—even though the pharmacy provided all of the required documentation during the audit.
After Caremark issued its audit findings, our team moved quickly to assess the allegations and develop a targeted appeal strategy. We challenged the audit’s conclusions head on, leveraging the pharmacy’s documentation and a focused legal framework to dispute the claimed deficiencies. The result? A full reversal of all audit findings, with Caremark rescinding all of its clawbacks.
PBMs want pharmacy owners to believe that their audit findings are final, but our attorneys know that a notice of findings is only the first step in the appeal process. We regularly fight back against unjust findings from some of the largest PBMs in the nation, from unsubstantiated affiliation allegations to vague prior authorization concerns. With the right strategy and advocacy, pharmacies can successfully push back against PBMs’ aggressive recoupment tactics, protecting their bottom line, reputation, and network status.
Health Law Alliance continues to deliver results for pharmacies facing PBM audits and related enforcement actions nationwide. If your pharmacy has received adverse audit findings, there is no better team to have on your side. Contact us today and see how we can help you.
MORE ARTICLES BY CATEGORY
HLA’s Latest PBM Win Highlights the Dangers of Inventory Discrepancies
Inventory discrepancies are one of the first things PBMs look for during an audit. Even minor clerical errors like entering the incorrect NDC or failing to return a medication to stock can snowball, creating major financial risks that could place your pharmacy in jeopardy.
Read More >>DOJ Targets Ketamine Clinics: Federal Charges Lead to Prison and Probation for Two Providers
The explosion in demand for ketamine-assisted psychotherapy (“KAP”) has garnered significant media attention over the past few years—and the federal government has taken notice.
Read More >>Defeating Optum: How HLA Won Full Termination Reversals for 7 New York Pharmacies
Health Law Alliance successfully reversed pending terminations for 7 New York pharmacies. Read more about how our PBM audit team achieved this stunning reversal.
Read More >>Ketamine Marketing Risks for Mental Health Providers
Ketamine marketing is under increasing regulatory scrutiny, with providers facing risk over claims, off-label promotion, and patient targeting. Even well-intentioned messaging can trigger audits or enforcement if it crosses compliance lines.
Read More >>
